FAM215A and neoplasm: Results showed that AC104971.3 (p < 0.01), AC021678.2 (p < 0.01), LINC02413 (p < 0.05), AL161781.2 (p < 0.05), and LY86-AS1 (p < 0.01) were significantly downregulated in clinical LUAD tumor tissues, and that FAM215A expression was not significantly different but slightly increased in tumor samples (Figure S3).